| 2.11 Data as of 3:59pm ET |  -0.04 / -1.86%Today’s Change | 1.90 Today|||52-Week Range 4.78 | -35.08% Year-to-Date |
| Uroplasty Delays 10-K Filing Jun 14 / Benzinga |
| Previous close | 2.15 |
| Today’s open | 2.08 |
| Day’s range | 2.07 - 2.15 |
| Volume | 22,857 |
| Average volume (3 months) | 50,583 |
| Market cap | $45.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +23.81% |
| Earnings growth (this year) | +13.75% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +9.03% |
| P/E ratio | NM |
| Price/Sales | 2.31 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| DCTHDelcath Systems Inc | +0.02 | +3.71% |
| ARDMAradigm Corp | +0.01 | +3.76% |
| RVPRetractable Technolo... | +0.05 | +3.57% |
| MELAMELA Sciences Inc | -0.03 | -3.42% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $22.4M |
| Annual profit (last year) | -$3.3M |
| Net profit margin | -14.74% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Rob C. Kill |
Chief Operating Officer & Secretary Susan Hartjes Holman |
Corporate headquarters Minnetonka, Minnesota |
.
